Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) Short Interest Up 102.8% in March

Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) saw a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 7,300 shares, an increase of 102.8% from the February 28th total of 3,600 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is currently 73.0 days.

Santhera Pharmaceuticals Price Performance

OTCMKTS SPHDF opened at $17.01 on Friday. Santhera Pharmaceuticals has a 52 week low of $16.00 and a 52 week high of $17.01. The firm’s 50-day simple moving average is $11.37 and its two-hundred day simple moving average is $11.06.

Santhera Pharmaceuticals Company Profile

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes Vamorolone, which is being developed for the treatments of Duchenne muscular dystrophy (DMD).